Sector
PharmaceuticalsOpen
₹2Prev. Close
₹0Turnover(Lac.)
₹0.04Day's High
₹2Day's Low
₹1.952 Week's High
₹052 Week's Low
₹0Book Value
₹1.16Face Value
₹10Mkt Cap (₹ Cr.)
4.29P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 22.59 | 22.59 | 22.59 | 22.59 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -19.81 | -19.24 | -18.83 | -18.66 |
Net Worth | 2.78 | 3.35 | 3.76 | 3.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Revenue | 42.81 | 38.66 | 32.85 | 27.45 |
yoy growth (%) | 10.73 | 17.67 | 19.68 | 16.79 |
Raw materials | -28.68 | -27.73 | -18.84 | -5.95 |
As % of sales | 66.98 | 71.73 | 57.35 | 21.68 |
Employee costs | -0.63 | -1.08 | -1.04 | -1 |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Profit before tax | 4.1 | 3.67 | 1.85 | 1.22 |
Depreciation | -7.69 | -3.3 | -5.7 | -7.05 |
Tax paid | -0.65 | -0.34 | 0.22 | 0.06 |
Working capital | 12.24 | -30.5 | 2.3 | 2.33 |
Other operating items |
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.73 | 17.67 | 19.68 | 16.79 |
Op profit growth | 69.07 | -18.21 | -31.19 | 60.39 |
EBIT growth | 11.95 | 17.62 | -41.59 | 94.07 |
Net profit growth | 3.66 | 60.28 | 60.48 | 53.56 |
| Particulars (Rupees in Crores.) | Mar-2023 | Mar-2022 |
|---|---|---|
Gross Sales | 0.17 | 0.15 |
Excise Duty | 0 | 0 |
Net Sales | 0.17 | 0.15 |
Other Operating Income | 0 | 0 |
Other Income | 0 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,648 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,549 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.1 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,313.3 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,227 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
A N Singh
Director
Padma Singh
Director
Jeetainder Roy Gour
Company Secretary
Sada Naga Latha
Executive Director & CEO
Dattatreya Rao
Plot No 59 Road No 12,
TSIIC Tech Park IDA Nacharam,
Telangana - 500076
Tel: 91-40-65552697/64565544
Website: http://www.celestialbiolabs.com
Email: cs@celestialbiolabs.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19, 1997 as Celestial Technologies Private Limited. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the c...
Read More
Reports by Celestial Biolabs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.